News

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
The Kings still have a little under $6 million of cap space, but most of their offseason work appears to be complete.
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
I reiterate my buy rating on VXF, citing compelling valuation and emerging technical strength in US SMID caps outside the S&P ...
A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...